Summary

Market Overview
The Global Point of Care Coagulation Testing Devices Market was valued at USD 1.84 Billion in 2024 and is projected to reach USD 2.58 Billion by 2030, growing at a CAGR of 5.79% during the forecast period. This market is experiencing strong momentum, driven by the growing prevalence of thrombotic and bleeding disorders such as deep vein thrombosis (DVT), pulmonary embolism, myocardial infarction, hemophilia, and von Willebrand disease.
These conditions, increasingly common due to aging populations and lifestyle-related factors, demand frequent and timely coagulation monitoring—especially among patients undergoing long-term anticoagulant therapies. The need for rapid diagnostics in emergency rooms, surgical units, anticoagulation clinics, and home healthcare is fueling demand for point of care (POC) coagulation devices that deliver accurate results in minutes.
A notable trend driving this market is the healthcare industry’s shift toward decentralized diagnostics, favoring portable, easy-to-use devices over traditional, centralized lab testing. This transformation is enhancing clinical decision-making, minimizing procedural delays, and improving patient care across a variety of care settings.
Key Market Drivers
Rising Prevalence of Cardiovascular and Hemostatic Disorders
The rising burden of cardiovascular diseases (CVDs) and hemostatic disorders is a primary growth catalyst. According to the World Health Organization, CVDs are responsible for approximately 17.9 million deaths annually, accounting for 32% of all global fatalities. One-third of these occur prematurely, before the age of 70.
In the United States alone, CVDs caused 930,000 deaths in 2020, making them the leading cause of mortality. Similarly, 2.2 million deaths across the Americas in 2021 were attributed to cardiovascular conditions. Despite a decline in mortality rates over recent decades, the absolute number of cases remains high, driven by aging populations and lifestyle-related risk factors.
Key Market Challenges
High Cost of Devices and Consumables
One of the most significant barriers to market growth is the high cost associated with POC coagulation testing systems. These devices often involve substantial upfront capital investment, particularly when equipped with wireless connectivity, data integration tools, and automated features.
Recurring expenses on test cartridges, reagents, maintenance, and software updates further strain hospital and clinic budgets—particularly in low-resource settings and developing regions. For home users, the cost of consumables over time can lead to reduced testing frequency or non-compliance, which compromises treatment safety and outcomes.
In public healthcare systems where budgets are constrained, procurement decisions often prioritize cost over long-term clinical value. Reimbursement inconsistencies further discourage adoption of these technologies in outpatient and remote care environments. Additionally, premium-priced consumables for advanced coagulation tests such as TEG and ROTEM are often limited to larger, better-funded hospitals.
Key Market Trends
Integration of Digital Connectivity and Telehealth Solutions
One of the most transformative trends reshaping this market is the digital evolution of POC coagulation devices. Modern analyzers now feature Bluetooth and Wi-Fi capabilities, allowing for instant transmission of results to electronic health record (EHR) systems or secure cloud platforms.
This connectivity enables remote patient monitoring, particularly for individuals on anticoagulants such as warfarin or DOACs. Physicians can monitor INR/PT levels in real time, adjust dosages, and enhance treatment compliance—all without in-person visits.
Smartphone apps paired with these devices offer:
• Guided test procedures
• Visual display of results
• Trend analysis
• Real-time alerts and notifications
This ecosystem supports telehealth platforms, enabling virtual consultations and improving access in rural or home-based settings. Remote diagnostics, firmware updates, and device troubleshooting via apps are also streamlining usability and reducing support burdens.
Key Market Players
• F. Hoffmann-La Roche Ltd.
• Abbott Laboratories
• Werfen, S.A.
• Siemens Healthineers
• Helena Laboratories Corporation
• Medtronic plc
• Koninklijke Philips N.V.
• Alere Inc.
• HemoSonics, LLC
• Sysmex Corporation
Market Segmentation
By Device Type:
• Anticoagulation Monitoring Devices
• Platelet Function Monitoring Devices
• Viscoelastic Coagulation Monitoring Devices
• Others
By Product:
• Instruments/Analyzers
• Consumables & Accessories
By End User:
• Hospitals
• Clinics
• Home Care Settings
• Others
By Region:
• North America
o United States
o Canada
o Mexico
• Europe
o France
o United Kingdom
o Italy
o Germany
o Spain
• Asia-Pacific
o China
o India
o Japan
o Australia
o South Korea
• South America
o Brazil
o Argentina
o Colombia
• Middle East & Africa
o South Africa
o Saudi Arabia
o UAE
Competitive Landscape
The report provides detailed profiles and strategic insights for leading companies operating in the Global Point of Care Coagulation Testing Devices Market. Analysis includes product innovation, market positioning, technological advancements, and global footprint.
Available Customizations
TechSci Research offers customizable elements in this report to align with specific business needs. Available options include:
• In-depth analysis and profiling of up to five additional market players
Let me know if you'd like this version adapted into a presentation deck, executive summary, or slide notes for a meeting!

ページTOPに戻る

Table of Contents

1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, and Trends
4. Voice of Customer
5. Global Point of Care Coagulation Testing Devices Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Device Type (Anticoagulation Monitoring Devices, Platelet Function Monitoring Devices, Viscoelastic Coagulation Monitoring Devices, Others)
5.2.2. By Product (Instruments/Analyzers, Consumables & Accessories)
5.2.3. By End User (Hospitals, Clinics, Home Care Settings, Others)
5.2.4. By Company (2024)
5.2.5. By Region
5.3. Market Map
6. North America Point of Care Coagulation Testing Devices Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Device Type
6.2.2. By Product
6.2.3. By End User
6.2.4. By Country
6.3. North America: Country Analysis
6.3.1. United States Point of Care Coagulation Testing Devices Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Device Type
6.3.1.2.2. By Product
6.3.1.2.3. By End User
6.3.2. Mexico Point of Care Coagulation Testing Devices Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Device Type
6.3.2.2.2. By Product
6.3.2.2.3. By End User
6.3.3. Canada Point of Care Coagulation Testing Devices Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Device Type
6.3.3.2.2. By Product
6.3.3.2.3. By End User
7. Europe Point of Care Coagulation Testing Devices Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Device Type
7.2.2. By Product
7.2.3. By End User
7.2.4. By Country
7.3. Europe: Country Analysis
7.3.1. France Point of Care Coagulation Testing Devices Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Device Type
7.3.1.2.2. By Product
7.3.1.2.3. By End User
7.3.2. Germany Point of Care Coagulation Testing Devices Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Device Type
7.3.2.2.2. By Product
7.3.2.2.3. By End User
7.3.3. United Kingdom Point of Care Coagulation Testing Devices Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Device Type
7.3.3.2.2. By Product
7.3.3.2.3. By End User
7.3.4. Italy Point of Care Coagulation Testing Devices Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Device Type
7.3.4.2.2. By Product
7.3.4.2.3. By End User
7.3.5. Spain Point of Care Coagulation Testing Devices Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Device Type
7.3.5.2.2. By Product
7.3.5.2.3. By End User
8. Asia-Pacific Point of Care Coagulation Testing Devices Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Device Type
8.2.2. By Product
8.2.3. By End User
8.2.4. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Point of Care Coagulation Testing Devices Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Device Type
8.3.1.2.2. By Product
8.3.1.2.3. By End User
8.3.2. India Point of Care Coagulation Testing Devices Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Device Type
8.3.2.2.2. By Product
8.3.2.2.3. By End User
8.3.3. South Korea Point of Care Coagulation Testing Devices Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Device Type
8.3.3.2.2. By Product
8.3.3.2.3. By End User
8.3.4. Japan Point of Care Coagulation Testing Devices Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Device Type
8.3.4.2.2. By Product
8.3.4.2.3. By End User
8.3.5. Australia Point of Care Coagulation Testing Devices Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Device Type
8.3.5.2.2. By Product
8.3.5.2.3. By End User
9. South America Point of Care Coagulation Testing Devices Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Device Type
9.2.2. By Product
9.2.3. By End User
9.2.4. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Point of Care Coagulation Testing Devices Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Device Type
9.3.1.2.2. By Product
9.3.1.2.3. By End User
9.3.2. Argentina Point of Care Coagulation Testing Devices Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Device Type
9.3.2.2.2. By Product
9.3.2.2.3. By End User
9.3.3. Colombia Point of Care Coagulation Testing Devices Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Device Type
9.3.3.2.2. By Product
9.3.3.2.3. By End User
10. Middle East and Africa Point of Care Coagulation Testing Devices Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Device Type
10.2.2. By Product
10.2.3. By End User
10.2.4. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Point of Care Coagulation Testing Devices Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Device Type
10.3.1.2.2. By Product
10.3.1.2.3. By End User
10.3.2. Saudi Arabia Point of Care Coagulation Testing Devices Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Device Type
10.3.2.2.2. By Product
10.3.2.2.3. By End User
10.3.3. UAE Point of Care Coagulation Testing Devices Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Device Type
10.3.3.2.2. By Product
10.3.3.2.3. By End User
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments
13. Disruptions: Conflicts, Pandemics and Trade Barriers
14. Porters Five Forces Analysis
14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products
15. Competitive Landscape
15.1. F. Hoffmann-La Roche Ltd.
15.1.1. Business Overview
15.1.2. Company Snapshot
15.1.3. Products & Services
15.1.4. Financials (As Reported)
15.1.5. Recent Developments
15.1.6. Key Personnel Details
15.1.7. SWOT Analysis
15.2. Abbott Laboratories
15.3. Werfen, S.A.
15.4. Siemens Healthineers
15.5. Helena Laboratories Corporation
15.6. Medtronic plc
15.7. Koninklijke Philips N.V.
15.8. Alere Inc.
15.9. HemoSonics, LLC
15.10. Sysmex Corporation
16. Strategic Recommendations
17. About Us & Disclaimer